Clinical trial
Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
NCT07673640 is registered in ClinicalTrials.gov with ShanShan Li as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
- Lead sponsor
- ShanShan Li
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 2, 2026
- Completion date
- December 31, 2028
- Enrollment
- 300 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
non-segmental vitiligo (nsv)